Table 3.
Disease duration | NMSSI | Cardio vascular | Sleep/fatigue | Mood/cognition | Perceptual/hallucination | Attention/memory | Gastro-intestinal | Urinary | Sexual function | Miscellaneous |
---|---|---|---|---|---|---|---|---|---|---|
< 5 years (n = 37) | 0.213 | 0.398 | 0.137 | 0.114 | 0.672 | 0.036 | 0.191 | 0.721 | 0.031 | 0.130 |
5–9 years (n = 42) | 0.482 | 0.843 | 0.792 | 0.819 | 0.717 | 0.947 | 0.919 | 0.795 | 0.328 | 0.058 |
10–14 years (n = 19) | 0.806 | 0.211 | 0.349 | 0.928 | 0.313 | 0.604 | 0.984 | 0.557 | 0.500 | 0.114 |
> 15 years (n = 9) | 0.629 | 0.891 | 0.082 | 0.922 | 0.125 | 0.813 | 0.531 | 0.406 | 0.375 | 0.828 |
We compared the repeated test in 2 years in 107 patients. Data were obtained using the Wilcoxon signed-rank test, and P values are shown. P < .017 indicates significance.